Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

638 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid.
Fujioka Y, Hata N, Akagi Y, Kuga D, Hatae R, Sangatsuda Y, Michiwaki Y, Amemiya T, Takigawa K, Funakoshi Y, Sako A, Iwaki T, Iihara K, Mizoguchi M. Fujioka Y, et al. Among authors: akagi y. J Neurooncol. 2021 Mar;152(1):47-54. doi: 10.1007/s11060-020-03682-7. Epub 2021 Jan 8. J Neurooncol. 2021. PMID: 33417137 Free PMC article.
Current Trends and Healthcare Resource Usage in the Hospital Treatment of Primary Malignant Brain Tumor in Japan: A National Survey Using the Diagnostic Procedure Combination Database (J-ASPECT Study-Brain Tumor).
Yoshimoto K, Kada A, Kuga D, Hatae R, Murata H, Akagi Y, Nishimura K, Kurogi R, Nishimura A, Hata N, Mizoguchi M, Sayama T, Iihara K. Yoshimoto K, et al. Among authors: akagi y. Neurol Med Chir (Tokyo). 2016 Nov 15;56(11):664-673. doi: 10.2176/nmc.oa.2016-0172. Epub 2016 Sep 27. Neurol Med Chir (Tokyo). 2016. PMID: 27680329 Free PMC article.
Deferred radiotherapy and upfront procarbazine-ACNU-vincristine administration for 1p19q codeleted oligodendroglial tumors are associated with favorable outcome without compromising patient performance, regardless of WHO grade.
Hata N, Yoshimoto K, Hatae R, Kuga D, Akagi Y, Suzuki SO, Iwaki T, Shono T, Mizoguchi M, Iihara K. Hata N, et al. Among authors: akagi y. Onco Targets Ther. 2016 Nov 17;9:7123-7131. doi: 10.2147/OTT.S115911. eCollection 2016. Onco Targets Ther. 2016. PMID: 27895504 Free PMC article.
638 results